Alexandria Real Estate Equities vs Healthpeak Properties
ARE and DOC side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ARE and DOC compare
Healthpeak Properties is the larger company, worth 1.8 times as much as Alexandria Real Estate Equities ($14.1B against $7.9B).
Healthpeak Properties grew revenue faster over the last twelve months (5.5% versus −9.9% for Alexandria Real Estate Equities).
Healthpeak Properties keeps more of each dollar of sales as profit, with a net margin of 8.2% compared with −51.8% at Alexandria Real Estate Equities.
Both pay dividends: Alexandria Real Estate Equities yields 6.4% and Healthpeak Properties 6.0%.
Healthpeak Properties scores higher on the StockData Score (8 against 7 for Alexandria Real Estate Equities), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ARE | DOC |
|---|---|---|
| Size and price | ||
| Market cap | $7.9B | $14.1B |
| Share price | $45.08 | $20.38 |
| Change, 1 year | −16.9% | 15.1% |
| Change, 5 years | −78.2% | −40.4% |
| Beta (5Y) | 1.01 | 0.71 |
| Employees | 514 | 411 |
| StockData Score | ||
| Total score | 7 | 8 (better) |
| Valuation score | 3 (better) | 1 |
| Growth score | 0 | 4 (better) |
| Performance score | 0 | 0 |
| Health score | 0 | 0 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | – | 58.2× |
| P/S | 2.8× (better) | 4.8× |
| P/B | 0.5× (better) | 1.8× |
| EV/EBITDA | – | 7.5× |
| Fair value | $89.84 | $16.85 |
| Margin of safety | 49.8% (better) | −20.9% |
| Growth | ||
| Revenue growth (TTM) | −9.9% | 5.5% (better) |
| Revenue growth, 5Y average | 9.9% | 11.4% (better) |
| Net income growth (TTM) | – | 47.5% |
| EPS growth (TTM) | – | 45.8% |
| EPS growth, 5Y average | – | −33.5% |
| Profitability | ||
| Net margin | −51.8% | 8.2% (better) |
| Return on equity | −9.1% | 3.1% (better) |
| Financial health | ||
| Altman Z-score | 0.38 | 0.83 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Dividend yield | 6.4% (better) | 6.0% |
| Payout ratio | – | 348% |
| Years of dividend growth | 0 | 1 (better) |
| Dividend growth, 5Y average | 2.0% (better) | −3.8% |
| Buyback yield | 0.00% | 0.72% (better) |
| Shareholder yield | 6.4% | 6.7% (better) |
| Ownership | ||
| Held by institutions | 97.4% | 95.9% |
| Held by insiders | 1.7% | 0.34% |
| Insider net buying, 12 months | $1.3M (better) | −$341K |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 3.8% | 3.3% |
Go deeper
- ARE stock overview
- ARE income statement
- ARE valuation and score
- DOC stock overview
- DOC income statement
- DOC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.